Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519330) titled 'Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection' on April 2.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Huahui Health
Condition:
Chronic Hepatitis B Virus Infection
Intervention:
Biological: HH-006
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: April 29, 2026
Target Sample Size: 45
To know more, visit https://clinicaltrials.gov/study/NCT07519330
Published by HT Digi...